Global Alliance to Enable Secure Sharing of Genomic and Clinical Data
Monday, June 10, 2013
Over 70 leading organizations have taken the first steps to form an international alliance dedicated to enabling secure sharing of genomic and clinical data.

Combined Immunotherapy Shows Promising Results Against Advanced Melanoma
Monday, June 10, 2013
Combining two cancer immunotherapy drugs in patients with advanced melanoma produced rates of tumor regression that appeared greater than in prior trials with either drug alone.

AMRI Announces Appointment of Chairman of the Board of Directors
Friday, June 07, 2013
Company has appointed William S. Marth as Chairman of the Board, effective June 5, 2013.

SentoClone Significantly Strengthens its Global Patent Portfolio
Friday, June 07, 2013
New patents granted in Japan, the USA and Europe.

BioLineRx Enrolls First Patient in Phase 2 Clinical Trial for BL-8040
Friday, June 07, 2013
Partial results expected in Q4 2013.

Valneva Announces the Sale of its Clinical Manufacturing Operations to Biological E
Friday, June 07, 2013
Next step in broadening an excellent strategic partnership.

CytomX Announces Global Strategic Collaboration with Pfizer
Friday, June 07, 2013
CytomX eligible to receive approximately $25 million in upfront, research reimbursement and preclinical milestone payments, $610 million in regulatory and sales milestones, plus tiered royalties on sales.

CovalX and Bruker Daltonics Announce Strategic Collaboration
Thursday, June 06, 2013
The agreement aims to advance protein research in the area of protein interactions and macromolecular characterization by supporting the combination of the two company’s technologies.

<<	1 2 3 4 5 6 7	>>
Showing Results 21 - 30 of 2319